Director, Executive Officer · ASP Isotopes Inc. · Common Stock
Open-market sale
$845K reported value · 1.4% of prior position
Disclosed 9 business days after execution (deadline: 2)
First recorded trade by this actor in this security
1 other actor traded the same direction within 14 days
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 27 | Kiessling HeatherChief Financial Officer | Open-market sale | SELL | $48K 21.8K sh | Oct 21, 2026 traded Oct 16, 2026 | |
| 29 | Ryan Robert John AndrewDirector | Open-market purchase | BUY | $22K 8,000 sh | Sep 30, 2026 traded Sep 28, 2026 | |
| 24 | Hunter Ralph L. JRDirector | Grant or award | A | — 10.5K sh | Nov 28, 2025 traded Sep 6, 2025 | |
| 18 | Mann Paul ElliotDirector, Executive Officer | Open-market sale · 10b5-1 plan | SELL | $288K 50.0K sh | Nov 28, 2025 traded Nov 25, 2025 | |
| 36 | Ainscow Donald GeorgeEVP, Gen Counsel, Secretary | Grant or award | A | — 400.0K sh | Nov 28, 2025 traded Aug 1, 2025 | |
| 19 | Ainscow RobertInterim CEO and COO | Open-market sale · 10b5-1 plan | SELL | $144K 25.0K sh | Nov 28, 2025 traded Nov 25, 2025 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $844,538
Mann Paul Elliot filed this Form 4 reporting a open-market sale of ASPI on Nov 17, 2025. It became public on Nov 28, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.